$ICPT Is FGF19 an oncogenic promoter for HCC ? This month’s Hepatology discusses the rising incidence of NAFLD and HCC FGF19 promotion seems to be a bad combination for long term NASH treatment- my opinion only, seek other alternative opinions
  • 2